EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+25.68%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$270M
AUM Growth
+$270M
(+25%)
Cap. Flow
+$38.6M
Cap. Flow
% of AUM
14.28%
Top 10 Holdings %
Top 10 Hldgs %
73.27%
Holding
33
New
7
Increased
6
Reduced
8
Closed
4
Top Buys
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$23.7M |
| 2 |
Kura Oncology
KURA
|
$20.6M |
| 3 |
Cytokinetics
CYTK
|
$14.8M |
| 4 |
Galapagos
GLPG
|
$10.5M |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
$9.52M |
Top Sells
| 1 |
Atara Biotherapeutics
ATRA
|
$25.3M |
| 2 |
EPZM
Epizyme, Inc
EPZM
|
$12.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
$7.11M |
| 4 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$2.59M |
| 5 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
$1.98M |
Sector Composition
| 1 | Healthcare | 84.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
FibroGen
FGEN
$47.8M
| $37.1M | 11.64% | 1,216,473 -13,918 | -1% | -$424K |
|
|
FPRX
2
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $29.8M | 9.37% | 719,000 +570,000 | +383% | +$23.7M |
|
3
Travere Therapeutics
TVTX
$1.56B
| $23.6M | 7.42% | 1,224,384 +216,724 | +22% | +$4.18M |
|
|
4
Kura Oncology
KURA
$686M
| $20.6M | 6.46% | +2,450,000 | New | +$20.6M |
|
5
Assembly Biosciences
ASMB
$190M
| $15.8M | 4.95% | 2,098,302 +211,233 | +11% | +$1.59M |
|
|
6
Cytokinetics
CYTK
$4.23B
| $14.8M | 4.66% | +1,418,700 | New | +$14.8M |
|
7
Collegium Pharmaceutical
COLL
$1.22B
| $12.8M | 4.02% | 465,118 | – | – |
|
|
EPZM
8
DELISTED
Epizyme, Inc
EPZM
| $11.2M | 3.52% | 698,900 -793,800 | -53% | -$12.7M |
|
|
9
Galapagos
GLPG
$2.07B
| $10.5M | 3.31% | +167,361 | New | +$10.5M |
|
|
KITE
10
DELISTED
Kite Pharma, Inc.
KITE
| $10.2M | 3.21% | 166,000 -115,400 | -41% | -$7.11M |
|
11
Salarius Pharmaceuticals
SLRX
$2.94M
| $9.9M | 3.11% | 795,088 -138,603 | -15% | -$1.73M |
|
|
12
Ironwood Pharmaceuticals
IRWD
$214M
| $9.52M | 2.99% | +821,531 | New | +$9.52M |
|
|
NBRV
13
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $7.93M | 2.49% | 838,680 +3,150 | +0.4% | +$29.8K |
|
|
ATYR
14
aTyr Pharma
ATYR
$527M
| $7.77M | 2.44% | 790,462 -50,000 | -6% | -$491K |
|
|
KIN
15
DELISTED
Kindred Biosciences, Inc.
KIN
| $4.87M | 1.53% | 1,432,765 +109,334 | +8% | +$372K |
|
|
EIGR
16
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $4.18M | 1.31% | 2,843,170 | – | – |
|
17
Tempest Therapeutics
TPST
$44M
| $4.15M | 1.3% | +424,979 | New | +$4.15M |
|
|
GNVC
18
DELISTED
GenVec, Inc.
GNVC
| $3.53M | 1.11% | 1,920,913 -65,500 | -3% | -$121K |
|
|
CALA
19
DELISTED
Calithera Biosciences, Inc
CALA
| $3.18M | 1% | 415,480 | – | – |
|
20
Larimar Therapeutics
LRMR
$310M
| $2.32M | 0.73% | +369,000 | New | +$2.32M |
|
|
FWP
21
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $1.9M | 0.6% | 100,017 -1,978 | -2% | -$37.6K |
|
|
AKTX
22
Akari Therapeutics
AKTX
$24.8M
| $1.46M | 0.46% | 100,750 +41 | +0% | +$595 |
|
|
NRX
23
DELISTED
NEPHROGENEX INC COM
NRX
| $941K | 0.3% | +588,235 | New | +$941K |
|
|
QLTI
24
DELISTED
QLT Inc
QLTI
| $266K | 0.08% | 100,000 -538,900 | -84% | -$1.43M |
|
|
25
Atara Biotherapeutics
ATRA
$84.6M
| – | – | -803,458 | Closed | -$25.3M |
|